Former Aimmune CEO talks biotech's latest therapy for food allergies

1:50 PM ET Thu, 28 June 2018

Jim Cramer sits down with former Aimmune CEO Stephen Dilly to discuss how the company is fighting the country's most prevalent food allergies.